Sphingosine Kinase 2 Inhibition and Blood Sphingosine 1-Phosphate Levels
暂无分享,去创建一个
[1] W. Santos,et al. Structure-activity relationship studies and in vivo activity of guanidine-based sphingosine kinase inhibitors: discovery of SphK1- and SphK2-selective inhibitors. , 2015, Journal of medicinal chemistry.
[2] Mostafa H. Ahmed,et al. Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression. , 2014, The Journal of clinical investigation.
[3] Yuhuan Wang,et al. Mechanism of rapid elimination of lysophosphatidic acid and related lipids from the circulation of mice , 2013, Journal of Lipid Research.
[4] K. Rex,et al. Sphingosine Kinase Activity Is Not Required for Tumor Cell Viability , 2013, PloS one.
[5] R. Proia,et al. Sphingosine-1-phosphate Phosphatase 1 Regulates Keratinocyte Differentiation and Epidermal Homeostasis*♦ , 2013, The Journal of Biological Chemistry.
[6] W. Santos,et al. Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate. , 2012, The Biochemical journal.
[7] T. Kasten,et al. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1. , 2012, The Biochemical journal.
[8] Thomas P Mathews,et al. Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate. , 2011, The Biochemical journal.
[9] Thomas P Mathews,et al. Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells. , 2011, Journal of medicinal chemistry.
[10] O. Pabst,et al. Redistribution of Sphingosine 1-Phosphate by Sphingosine Kinase 2 Contributes to Lymphopenia , 2010, The Journal of Immunology.
[11] S. Kaneko,et al. S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species. , 2010, Cardiovascular research.
[12] R. Proia,et al. Sphingosine 1-Phosphate Lyase Deficiency Disrupts Lipid Homeostasis in Liver* , 2010, The Journal of Biological Chemistry.
[13] Jeremy C. Allegood,et al. Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers[S] , 2009, Journal of Lipid Research.
[14] V. Natarajan,et al. Lipid phosphate phosphohydrolase type 1 (LPP1) degrades extracellular lysophosphatidic acid in vivo. , 2009, The Biochemical journal.
[15] P. V. Van Veldhoven,et al. S1P‐lyase independent clearance of extracellular sphingosine 1‐phosphate after dephosphorylation and cellular uptake , 2008, Journal of cellular biochemistry.
[16] H. Bonkovsky,et al. Vascular Endothelium As a Contributor of Plasma Sphingosine 1-Phosphate , 2008, Circulation research.
[17] J. Cyster,et al. Finding a way out: lymphocyte egress from lymphoid organs , 2007, Nature Immunology.
[18] P. Gonzalez-Cabrera,et al. Tipping the gatekeeper: S1P regulation of endothelial barrier function. , 2007, Trends in immunology.
[19] B. Kinzel,et al. Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720. , 2006, Blood.
[20] R. Proia,et al. Essential Role for Sphingosine Kinases in Neural and Vascular Development , 2005, Molecular and Cellular Biology.
[21] R. Proia,et al. Mice Deficient in Sphingosine Kinase 1 Are Rendered Lymphopenic by FTY720* , 2004, Journal of Biological Chemistry.
[22] M. Vadas,et al. Activation of sphingosine kinase 1 by ERK1/2‐mediated phosphorylation , 2003, The EMBO journal.